Clearbridge Investments, LLC Intercept Pharmaceuticals, Inc. Transaction History

Clearbridge Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$39.09 - $53.44 $7,661 - $10,474	-196 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$48.35 - $118.68 $290 - $712	-6 Reduced 2.97%	196 $12,000
Q1 2019 May 15, 2019	SELL	$91.83 - $120.68 $13,958 - $18,343	-152 Reduced 42.94%	202 $23,000
Q2 2018 Aug 14, 2018	SELL	$60.0 - $85.67 $29,340 - $41,892	-489 Reduced 58.01%	354 $30,000
Q3 2017 Nov 14, 2017	BUY	$57.01 - $118.75 $16,076 - $33,487	282 Added 50.27%	843 $49,000
Q2 2017 Aug 14, 2017	BUY	N/A	561	561 $68,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Clearbridge Investments, LLC with notifications on news.